Vistra Corp. (NYSE:VST – Get Free Report) EVP Stephen J. Muscato sold 207,100 shares of the firm’s stock in a transaction that occurred on Friday, November 22nd. The shares were sold at an average price of $161.34, for a total transaction of $33,413,514.00. Following the transaction, the executive vice president now directly owns 318,287 shares in the company, valued at approximately $51,352,424.58. The trade was a 39.42 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website.
Vistra Stock Down 5.0 %
VST opened at $154.54 on Thursday. The business has a 50 day moving average of $129.97 and a 200-day moving average of $101.03. The stock has a market capitalization of $52.58 billion, a price-to-earnings ratio of 28.83, a P/E/G ratio of 1.98 and a beta of 1.09. The company has a current ratio of 1.11, a quick ratio of 0.99 and a debt-to-equity ratio of 4.68. Vistra Corp. has a 1-year low of $34.88 and a 1-year high of $168.67.
Vistra declared that its Board of Directors has approved a share buyback plan on Thursday, November 7th that authorizes the company to buyback $1.00 billion in shares. This buyback authorization authorizes the company to reacquire up to 2.1% of its shares through open market purchases. Shares buyback plans are typically a sign that the company’s board believes its shares are undervalued.
Vistra Increases Dividend
Analyst Upgrades and Downgrades
Several research firms recently issued reports on VST. BNP Paribas started coverage on shares of Vistra in a research note on Monday, October 14th. They issued an “outperform” rating and a $231.00 price objective for the company. UBS Group cut their target price on Vistra from $157.00 to $150.00 and set a “buy” rating on the stock in a report on Tuesday, October 22nd. JPMorgan Chase & Co. began coverage on Vistra in a research note on Thursday, October 17th. They set an “overweight” rating and a $178.00 price target for the company. Guggenheim raised their price objective on Vistra from $133.00 to $177.00 and gave the company a “buy” rating in a research note on Tuesday, October 8th. Finally, BMO Capital Markets upped their target price on Vistra from $146.00 to $147.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 29th. Ten research analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock has a consensus rating of “Buy” and an average target price of $149.10.
View Our Latest Stock Analysis on VST
Institutional Investors Weigh In On Vistra
Several hedge funds have recently made changes to their positions in the stock. Empire Life Investments Inc. acquired a new position in Vistra in the 3rd quarter valued at approximately $23,028,000. Terra Nova Asset Management LLC acquired a new stake in shares of Vistra during the 3rd quarter valued at about $842,000. Czech National Bank raised its position in Vistra by 12.4% in the third quarter. Czech National Bank now owns 69,987 shares of the company’s stock worth $8,296,000 after purchasing an additional 7,747 shares in the last quarter. CIBC Asset Management Inc raised its position in Vistra by 12.4% in the third quarter. CIBC Asset Management Inc now owns 50,380 shares of the company’s stock worth $5,972,000 after purchasing an additional 5,575 shares in the last quarter. Finally, Viking Fund Management LLC bought a new position in Vistra during the third quarter worth about $1,185,000. Institutional investors own 90.88% of the company’s stock.
About Vistra
Vistra Corp., together with its subsidiaries, operates as an integrated retail electricity and power generation company. The company operates through six segments: Retail, Texas, East, West, Sunset, and Asset Closure. It retails electricity and natural gas to residential, commercial, and industrial customers across states in the United States and the District of Columbia.
Further Reading
- Five stocks we like better than Vistra
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- How to Use Stock Screeners to Find Stocks
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Buy P&G Now, Before It Sets A New All-Time High
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Vistra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vistra and related companies with MarketBeat.com's FREE daily email newsletter.